Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 66

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 8
Chunk 66
---
 the sale of the NOLs, the Company can be liable to pay the
state of New Jersey up to $2.2 million of the surrendered NOLs

NOTE 10—
SEGMENT AND GEOGRAPHIC DATA

Operating
segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating
decision maker, who is responsible for allocating resources and assessing performance of operating segments, has been identified
as the Chief Executive Officer (the “CODM”). The Company conducts its business through two reportable
segments: Dental and Medical. These segments offer different products and services to various customer base. The CODM assesses the
financial performance of the segment and decides how to allocate resources based on Product sales, net, and operating income (loss).
Certain reclassifications have been made to the 2025 unaudited condensed consolidated financial statements to conform
to the 2024 unaudited condensed consolidated financial statement presentation. These reclassifications had no effect on
net loss or cash flows as previously reported.

The
Company provides general corporate services to its segments; however, these services are not considered when making operating decisions
and assessing segment performance. These services are reported under “Corporate Services” below and these include costs associated
with executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing
activities and public company compliance.

     15 

The
following tables present information about our reportable and operating segments for the three and nine months ended September 30, 2025,
and 2024:

 SCHEDULE OF REPORTABLE AND OPERATING SEGMENTS

    Corporate  
    Dental  
    Medical  
    Grand Total 

    Three Months ending September 30, 2025 

    Corporate  
    Dental  
    Medical  
    Grand Total 
  
    Product sales, net 
    $-  
    $2,318,993  
    $41,124  
    $2,360,117 
  
    Cost of products sold 
     -  
     718,481  
     766  
     719,247 
  
    Gross Margin 
     -  
     1,600,512  
     40,358  
     1,640,870 

    Salaries & employee benefits 
     387,591